Life 360 Innovations Inc.
Founded 2010 · 6 employees on LinkedIn · 2 known investors
Life360 Innovations Inc. develops, manufactures, and distributes licensed urology-related medical devices, including its Contino product. The company serves the Canadian market with its medical device manufacturing and distribution operations.
Also known as Life360 Innovations · Life360 Innovations Inc.
Investors · 2
Company profile
researched Aug 2026Life360 Innovations Inc. is a Canadian company that develops, manufactures and distributes urology-related licensed medical devices and consumer products, with a focus on male urinary incontinence. Its flagship product line is Contino®, a self-administered urethral insert for men with stress urinary incontinence (SUI), described by the company as a first-of-its-kind male urinary incontinence device and a new product category. Alongside Contino®, the company lists additional distributed products including 201 - HR® Lubricating Jelly and 280NW - EcoVue®.
The company states that the infrastructure and development capability built through the development and manufacture of Contino® supports its broader manufacturing and distribution activity across Canada. Contino® is licensed for sale in Canada by Health Canada following completion of a five-year, multi-site Canadian clinical trial, and the company has also conducted a post-market clinical follow-up study in the Greater Toronto Area. Company communications reference patents and licenses, clinical studies, and an investor-facing section of its website.
Founding story
Life360 Innovations was created out of an effort to solve an urgent personal need related to male urinary incontinence. Contino®, the device that became the impetus for the company, was invented by Ken Kunz, who according to the company is almost 90 years old and continues to use the device daily.
Business model
The company imagines, develops, manufactures and distributes licensed medical devices and related consumer products for urology, selling Contino® directly and through partner clinics that fit the device, with distribution across Canada.
Contino® is personally fitted to each user by a healthcare professional and then self-administered; after fitting, the device is available on a subscription basis with monthly home delivery. Coverage by major Canadian benefits providers allows the product to be treated as an eligible reimbursable expense under group benefit plans that cover urinary incontinence products.
Traction
Contino® is licensed by Health Canada, is offered through partner clinics in British Columbia and Ontario, and as of May 2020 was recognized as an eligible urinary incontinence product by five major Canadian benefits providers, with additional provider discussions underway; Medavie Blue Cross coverage was subsequently initiated. Foundational clinical study results were published in the Canadian Urology Association Journal, and a post-market clinical follow-up study was conducted in the Greater Toronto Area.
Latest developments
Company announcements include the appointment of Barbara Towns as Vice President Finance & Administration, the hiring of a Director of Professional Sales, initiation of Contino® coverage by Medavie Blue Cross, recognition by Rocket Builders for Life Sciences, and publication of the foundational Contino® clinical study in the Canadian Urology Association Journal.
▸Full profile — market position, technology, go-to-market, geography
Market position
Life360 Innovations operates in the Canadian male urinary incontinence market as a licensed medical device manufacturer and distributor. It has been named 'Ready to Rocket' in the Life Sciences category by Rocket Builders, listed by Medtech Outlook Magazine among the Top 20 Medtech Providers 2020, and named by Business Worldwide Magazine as one of the 20 Most Innovative Companies to Watch, 2020.
The company positions Contino® as an alternative to existing options for male urinary incontinence — absorbent products such as diapers and pads, penile compression devices such as clamps, external collection devices such as condom catheters, and surgery — presenting it as a distinct product category rather than a variant of these approaches.
Technology
Contino® is a licensed, self-administered urethral insert designed to manage bladder leakage in men. It is individually fitted by a healthcare professional and then used by the patient without further clinical assistance. Health Canada licensing followed a five-year, multi-site Canadian clinical trial, and foundational clinical study results were published in the Canadian Urology Association Journal.
Go-to-market
Life360 Innovations reaches users through healthcare professionals and partner clinics that fit Contino®, including physiotherapy and pelvic floor clinics in British Columbia and Ontario such as Ladner Physio Therapy, PG Pelvic Floor and Core Rehab, Envision Physiotherapy, Kare Physiotherapy and Advanced Pelvic Physiotherapy Centre. It also sells online via its own site and mycontino.com, supports reimbursement through private benefits providers, and builds awareness through the Canadian Continence Foundation and clinical publication of study results.
Men experiencing stress urinary incontinence and bladder leakage, together with the healthcare professionals and clinics that fit and recommend incontinence products.
Geography
Headquartered in Vancouver, British Columbia (Suite 1200, 555 West Hastings Street), with manufacturing and distribution of licensed medical devices across Canada and fitting clinics in British Columbia and Ontario.
Compiled by commissioned research from 4 cited public sources — announcements, filings, and press listed under research sources below.
Timeline · 3
launches, deals, and filingsLife360 Innovations announced that its Contino® urethral insert became formally covered as a urinary incontinence treatment option by Green Shield Canada, Canada Life (including Great West Life and London Life), Desjardins, Manulife and Sun Life, making it an eligible reimbursable expense under group benefits plans that cover UI products.
Contino® was licensed by Health Canada following completion of a five-year, multi-site Canadian clinical trial.
Contino® was recognized by The Canadian Continence Foundation, with a factsheet added to its Men's Room online resource centre for men's incontinence; Life360 Innovations also sponsors the foundation and donates a portion of each Contino® product sale or subscription.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
▸Research sources · 4
primary sources listed
- Life 360 Innovations Inc.life360innovations.com · web
4 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Life 360 Innovations Inc. do?
- Canadian medical device maker of Contino®, a self-administered urethral insert for male stress urinary incontinence.
- Who are Life 360 Innovations Inc.'s investors?
- Life 360 Innovations Inc.'s investors include SFU VentureLabs, WUTIF Capital.